Divergent role for TNF-α in IFN-γ-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-γ receptor 1 deficiency1

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3900-3907

  Janssen, Riny ^a   Van Wengen, Annelies ^a   Verhard, Els ^a   De Boer, Tjitske ^a   Zomerdijk, Timo ^a   Ottenhoff, Tom H M ^a   Van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GENOMIC DNA; INTERLEUKIN 12; RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CASE REPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII;

EID: 0036784626     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3900     Document Type: Article

References (28)

1. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman. and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227.
2. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol. Today 19:491.
3. Jouanguy, E., R. Doffinger, S. Dupuis, A. Pallier. F. Altare. and J. L. Casanova. 1999. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11:346.
4. Altare. F., D. Lammas. P. Revy, E. Jouanguy, R. Doffinger, S. Lamhamedi. P. Drysdale, D. Scheel-Toellner, J. Girdlestone, P. Darbyshire, et al. 1998. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J. Clin. Invest 102:2035.
5. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bemaudin. et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432.
6. de Jong, R., F. Altare. I. A. Haagen, D. G. Elferink, T. Boer, P. J. van Breda Vriesman, P. J. Kabel, J. M. Draaisma, J. T. van Dissel, F. P. Kroon, et al. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435.
7. Roesler, J., B. Kofink, J. Wendisch, S. Heyden, D. Paul, W. Friedrich, J. L. Casanova, W. Leupold, M. Gahr, and A. Rosen-Wolff. 1999. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-γ-receptor (IFNγR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp. Hematol. 27:1368.
8. Jouanguy, E., S. Dupuis, A. Pallier, R. Doffinger, M. C. Fondaneche, C. Fieschi, S. Lamhamedi-Cherradi, F. Altare, J. F. Emile, P. Lutz, et al. 2000. In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ. J. Clin. Invest 105:1429.
9. Dorman, S. E. and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101:2364.
10. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
11. Doffinger, R., E. Jouanguy, S. Dupuis, M. C. Fondaneche, J. L. Stephan, J. F. Emile, S. Lamhamedi-Cherradi, F. Altare, A. Pallier, G. Barcenas-Morales, et al. 2000. Partial interferon-γ receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J. Infect. Dis. 181:379.
12. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J. F. Emile, et al. 1999. A human IFNGRI small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370.
13. Dighe, A. S., M. A. Farrar, and R. D. Schreiber. 1993. Inhibition of cellular responsiveness to interferon-γ (IFNγ) induced by overexpression, of inactive forms of the IFNγ receptor. J. Biol. Chem. 268:10645.
14. Arend, S. M., R. Janssen, J. J. Gosen, H. Waanders, T. de Boer, T. H. Ottenhoff, and J. T. van Dissel 2001. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-γ receptor. Neth. J. Med. 59:140.
15. Verjans, G. M., J. H. Ringrose, L. van Alphen, T. E. Feltkamp, and J. G. Kusters. 1994. Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines. Infect. Immun. 62:2229.
16. Murray, H. W., and Z. A. Cohn. 1980. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J. Exp. Med. 152:1596.
17. Langermans, J. A., M. E. Van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568.
18. Dighe, A. S., D. Campbell, C. S. Hsieh, S. Clarke, D. R. Greaves, S. Gordon, K. M. Murphy, and R. D. Schreiber. 1995. Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3:657.
19. Ramana. C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23:96.
20. Gil, M. P., E. Bohn, A. K. O'Guin, C. V. Ramana, B. Levine, G. R. Stark, H. W. Virgin, and R. D. Schreiber 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98:6680.
21. Dupuis, S., C. Dargemont, C. Fieschi, N. Thomassin, S. Rosenzweig, J. Harris, S. M. Holland, R. D. Schreiber, and J. L. Casanova 2001. Impairment of mycobacterial but not viral immunity by a germline human STATI mutation. Science 293:300.
22. Dorman, S, E., G. Uzel, J. Roesler, J. S. Bradley, J. Bastian, G. Billman, S. King, A. Filie, J. Schermerhom, and S. M. Holland. 1999. Viral infections in interferon-γ receptor deficiency. J. Pediatr. 135:640.
23. Holland, S. M., S. E. Dorman, A. Kwon, I. F. Pitha-Rowe, D. M. Frucht, S. M. Gerstberger, G. J. Noel, P. Vesterhus, M. R. Brown, and T. A. Fleisher. 1998, Abnormal regulation of interferon-γ, interleukin-12, and tumor necrosis factor-α in human interferon-γ receptor 1 deficiency. J. Infect. Dis. 178:1095.
24. Vazquez-Torres, A., G. Fantuzzi, C. K. Edwards III, C. A. Dinarello, and F. C. Fang 2001. Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc, Natl. Acad. Sci. USA 98:2561.
25. Mastroeni, P., J. N. Skepper. and C. E. Hormaeche. 1995. Effect of anti-tumor necrosis factor α antibodies on histopathology of primary Salmonella infections. Infect. Immun. 63:3674.
26. Langermans, J. A., M. E. Van der Hulst, P. H. Nibbering, and R. van Furth. 1992. Endogenous tumor necrosis factor α is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant γ interferon-treated mice. Infect. Immun. 60:5107.
27. Yap, G. S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340.
28. Verhagen, C. E., T. de Boer, H. H. Smits, F. A. Verreck, E. A. Wierenga, M, Kurimoto, D. A. Lammas, D. S. Kumararatne, O. Sanal, F. P, Kroon, et al. 2000. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor β1 (IL-12Rβ1): evidence for an lL-12Rβ1-independent pathway of IL-12 responsiveness in human T cells. J. Exp. Med. 192:517.